In-vitro brain organotypic model of Progressive Multifocal Leukoencephalopathy
进行性多灶性白质脑病的体外脑器官模型
基本信息
- 批准号:8329124
- 负责人:
- 金额:$ 23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAffectAutoimmune DiseasesBiologicalBiologyBrainCancer PatientCell CommunicationCell Culture TechniquesCell LineCell modelCellsComplicationDNA VirusesDemyelinating DiseasesDevelopmentDiseaseEffectivenessEnvironmentEpidemicEpilepsyExhibitsFamilyGenomeHIVHumanImmunocompromised HostImmunosuppressive AgentsIn VitroIncidenceInfectionIntegration Host FactorsJC VirusKnowledgeLongitudinal StudiesMalignant NeoplasmsModelingMolecularMonoclonal AntibodiesMultiple SclerosisNeurobiologyNeurogliaNeurologicNeuronsOligodendrogliaOperative Surgical ProceduresOpportunistic InfectionsPathogenesisPatientsPatternPharmaceutical PreparationsPlayPolyomaviridaePopulationPredispositionProcessProgressive Multifocal LeukoencephalopathyQuality of lifeRare DiseasesRheumatoid ArthritisRoleStagingStructureSystemSystemic Lupus ErythematosusTestingTissue ModelViralVirusVirus Diseasesbasebrain cellbrain tissuecell transformationglial cell developmenthuman embryonic stem cellimprovedin vitro Modelin vivonatalizumabprogenitorresearch studyresponsetissue culturetransmission processtreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Progressive multifocal leukoencephalopathy (PML) is a devastating infection of the brain by JC virus, a virus that may remain dormant and inactive until its activation is triggered by immunological disturbances that produce immunosupression in humans. Patients affected by AIDS or immunosuppressive disorders such as cancer or rheumatological disorders are highly susceptible for developing PML. One of the most evident limiting factors in our lack of knowledge of the mechanisms of infection in PML is the lack of reliable in-vitro cell or tissue models for studying the pathobiology of JCV infection. This proposal directly addresses this critical desirable need for the development of an in-vitro brain tissue model of JCV infection. By taking advantage of surgically removed brain tissues from patients undergoing surgical treatment of epilepsy, we developed an in-vitro human organotypic brain tissue culture (HOBTC) system suitable for long-term studies of neuroglial cells, microvascular networks and neuronal-glial interactions. This proposal will further characterize the use of the in-vitro model of JCV infection in HOBTC to assess critical questions about the biology of JCV infection of neuroglia cells and cellular responses to infection, but most importantly to develop a model that may facilitate testing of potential approaches in the treatment of PML. We plan to characterize the profile of neuroglial cell responses to JCV infection in the HOBTC model and also to study the effects of HIV co-infection in the dynamic and patterns of neuroglia infection in the HOBTC model. We will study whether molecular differences and disarrangements in the JCV genome of viruses isolated from CSF of PML patients affect the dynamic and pattern of neuroglia infection in the HOBTC model. Our ability to develop an in-vitro tissue model of PML infection will improve the understanding of the biological mechanisms of JCV infection and above all identify viral and host factors that modulate and determine the pattern of infection of neuroglial cells within the CNS. That ability will also expedite the development of strategies to modify and control JCV infections and to eventually find specific treatments for PML.
PUBLIC HEALTH RELEVANCE: Progressive multifocal leukoencephalopathy (PML) is a rare but fatal infection of the brain produced by the JC virus, a virus that may remain dormant in humans until activation produced by immunosupression. The mechanisms and modes of invasion of the brain and remain unknown due to the lack of in-vitro models. This proposal focuses on the development of an in-vitro organotypic brain tissue culture system to study the mechanisms of JCV infection of brain cells and for testing potential strategies for treatment PML.
描述(由申请人提供):进行性多灶性白质脑病 (PML) 是一种由 JC 病毒引起的破坏性脑部感染,这种病毒可能保持休眠和非活动状态,直到被免疫紊乱触发而激活,从而产生人体免疫抑制。患有艾滋病或免疫抑制疾病(例如癌症或风湿病)的患者极易患上 PML。我们对 PML 感染机制缺乏了解的最明显的限制因素之一是缺乏可靠的体外细胞或组织模型来研究 JCV 感染的病理学。该提案直接解决了开发 JCV 感染的体外脑组织模型的迫切需要。通过利用接受癫痫手术治疗的患者手术切除的脑组织,我们开发了一种体外人体器官型脑组织培养(HOBTC)系统,适用于神经胶质细胞、微血管网络和神经元-胶质细胞相互作用的长期研究。该提案将进一步描述 HOBTC 中 JCV 感染体外模型的使用,以评估有关 JCV 感染神经胶质细胞的生物学和细胞对感染的反应的关键问题,但最重要的是开发一个模型,可以促进潜在的测试PML 的治疗方法。我们计划在 HOBTC 模型中表征神经胶质细胞对 JCV 感染的反应概况,并研究 HIV 共感染对 HOBTC 模型中神经胶质细胞感染动态和模式的影响。我们将研究从 PML 患者脑脊液分离的病毒 JCV 基因组的分子差异和排列是否影响 HOBTC 模型中神经胶质细胞感染的动态和模式。我们开发 PML 感染体外组织模型的能力将提高对 JCV 感染生物学机制的理解,最重要的是识别调节和确定中枢神经系统内神经胶质细胞感染模式的病毒和宿主因子。这种能力还将加快制定修改和控制 JCV 感染的策略,并最终找到针对 PML 的具体治疗方法。
公共卫生相关性:进行性多灶性白质脑病 (PML) 是一种罕见但致命的脑部感染,由 JC 病毒产生,这种病毒可能在人类体内保持休眠状态,直到通过免疫抑制激活为止。由于缺乏体外模型,侵入大脑的机制和模式仍然未知。该提案的重点是开发体外器官型脑组织培养系统,以研究 JCV 感染脑细胞的机制并测试治疗 PML 的潜在策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS A PARDO-VILLAMIZAR其他文献
CARLOS A PARDO-VILLAMIZAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS A PARDO-VILLAMIZAR', 18)}}的其他基金
Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis
神经结节病:临床表型、生物标志物和免疫发病机制
- 批准号:
10445211 - 财政年份:2022
- 资助金额:
$ 23万 - 项目类别:
Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis
神经结节病:临床表型、生物标志物和免疫发病机制
- 批准号:
10689680 - 财政年份:2022
- 资助金额:
$ 23万 - 项目类别:
Emerging Neuroviruses and Neurological Inflammatory Diseases
新兴神经病毒和神经炎症性疾病
- 批准号:
9976612 - 财政年份:2019
- 资助金额:
$ 23万 - 项目类别:
Emerging Neuroviruses and Neurological Inflammatory Diseases
新兴神经病毒和神经炎症性疾病
- 批准号:
10627760 - 财政年份:2019
- 资助金额:
$ 23万 - 项目类别:
Emerging Neuroviruses and Neurological Inflammatory Diseases
新兴神经病毒和神经炎症性疾病
- 批准号:
10396976 - 财政年份:2019
- 资助金额:
$ 23万 - 项目类别:
In-vitro brain organotypic model of Progressive Multifocal Leukoencephalopathy
进行性多灶性白质脑病的体外脑器官模型
- 批准号:
8437132 - 财政年份:2012
- 资助金额:
$ 23万 - 项目类别:
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
中枢神经系统机会性感染在艾滋病毒脑炎后续发展中的作用
- 批准号:
7885443 - 财政年份:2008
- 资助金额:
$ 23万 - 项目类别:
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
中枢神经系统机会性感染在艾滋病毒脑炎后续发展中的作用
- 批准号:
8113327 - 财政年份:2008
- 资助金额:
$ 23万 - 项目类别:
Role of CNS Opportunistic Infections in Subsequent Development of HIV Encephaliti
中枢神经系统机会性感染在艾滋病毒脑炎后续发展中的作用
- 批准号:
8304304 - 财政年份:2008
- 资助金额:
$ 23万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
HIV Tat-associated Sensory Neuropathy and the Contribution of Toll-like Receptor Pathway
HIV Tat 相关感觉神经病变和 Toll 样受体通路的贡献
- 批准号:
10838798 - 财政年份:2023
- 资助金额:
$ 23万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 23万 - 项目类别: